Select regions whose content you would like to see
Technology used by the NHS in England will need to conform to minimum technical standards in future, under plans outlined by the UK government. 18 Oct 2018
The UK government should help industry to fund the cost of stockpiling medicines ahead of Brexit, a trade body has said. 17 Oct 2018
Businesses found to have infringed patent rights can face potentially substantial bills for compensation and a block on the manufacture, supply and sale of infringing products.
Businesses that are involved in patent litigation incur costs when engaging legal advisers. Some of these costs may be recoverable from the other side, but there are rules around costs that parties to litigation should familiarise themselves with.
Patent rights are property rights and as such can be assigned, mortgaged, licensed, etc… However, when assigning a patent there are strict requirements and procedures that the patentee must adhere to and follow.
Bringing or defending a patent claim before the courts can be a daunting prospect, not least because of the complicated nature of patents and patent law. It is vital that businesses understand the procedures that govern how patent trials operate.
When patents are granted they provide inventors up to 20 years of protection for their invention, but there are circumstances in which patents can be revoked.
Businesses can face claims of patent infringement if they carry out acts infringing patented products or processes without the consent of patent rights holders. However, UK patent law contains a number of defences against infringement which businesses may...
ANALYSIS: A stalemate in Brexit talks means businesses in the life sciences sector face a number of uncertainties over their future operations. The situation requires those companies to prepare for a variety of possible Brexit scenarios. 05 Oct 2018
Manufacturers of new biological or biosimilar medicines could obtain a licence to sell their medicines in the UK within 67 days of making an application under a new scheme aimed at minimising the impact of a 'no deal' Brexit. 05 Oct 2018
Join My Out-Law
Already signed up to My Out-Law?
The current market can be both challenging and interesting for companies in the Life Sciences sector. We are committed to leveraging our knowledge of the law to create a business tool to provide you with strategic advice and support. We are able to identify and capitalise on new opportunities, defend and open up markets and help you diversify so you achieve your commercial objectives.
More about Life Sciences
Partner - Head of IP & Life Sciences